Rchr
J-GLOBAL ID:201801019570926382   Update date: Feb. 01, 2024

Arai Satoko

新井 郷子 | Arai Satoko
Affiliation and department:
Job title: Vice Director
Homepage URL  (1): https://iamaim.jp/
Research field  (2): Immunology ,  Pathobiochemistry
Research keywords  (3): 炎症収束学 ,  Restorative macrophage ,  Apoptosis inhibitor of Macrophage (AIM)
Research theme for competitive and other funds  (13):
  • 2023 - 2026 重症肺感染症における宿主防御応答向上のメカニズム解明
  • 2021 - 2024 炎症性組織レジリエンスと組織障害エントロピーの統合的理解と炎症収束学の創成
  • 2021 - 2024 Elucidation of the roles of restorative macrophages in inflammatory tissue resilience
  • 2020 - 2023 食細胞機構を用いた視機能劣化(アイフレイル)および眼疾患の制御
  • 2018 - 2021 脂肪肝肝癌の発症機序におけるAIMの関連に関する研究
Show all
Papers (57):
  • Keisuke Yasuda, Shieri Shimodan, Natsumi Maehara, Aika Hirota, Ruka Iijima, Akemi Nishijima, Haruka Mori, Ran Toyama, Atsumi Ito, Yuri Yoshikawa, et al. AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. Journal of autoimmunity. 2023. 142. 103149-103149
  • Hotaka Nemoto, Megumi Honjo, Satoko Arai, Toru Miyazaki, Makoto Aihara. Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension. Journal of cellular physiology. 2023. 238. 10. 2451-2467
  • Michiko Takimoto-Sato, Masaru Suzuki, Hiroki Kimura, Haiyan Ge, Munehiro Matsumoto, Hironi Makita, Satoko Arai, Toru Miyazaki, Masaharu Nishimura, Satoshi Konno. Apoptosis inhibitor of macrophage (AIM)/CD5L is involved in the pathogenesis of COPD. Respiratory research. 2023. 24. 1. 201-201
  • Kyohei Matsuura, Natsumi Maehara, Aika Hirota, Ayaka Eguchi, Keisuke Yasuda, Kaori Taniguchi, Akemi Nishijima, Nobuyuki Matsuhashi, Yoshiyuki Shiga, Rumi Ishii, et al. Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1. Communications biology. 2022. 5. 1. 783-783
  • Natsumi Maehara, Kaori Taniguchi, Ami Okuno, Hideaki Ando, Aika Hirota, Zhiheng Li, Ching-Ting Wang, Satoko Arai, Toru Miyazaki. AIM/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic stroke. Cell reports. 2021. 36. 11. 109693-109693
more...
MISC (43):
more...
Lectures and oral presentations  (5):
  • A role of the phagocytic removal system in resolution of inflammation and its therapeutic implication
    (2022)
  • 1. マクロファージ由来タンパク質AIMによるがん細胞の除去機構を利用した肝細胞がん治療法の開発
    (JCRP平成29年度市民向け成果発表会 2018)
  • 4. Study on activation of circulating AIM in multiple diseases-from NASH-HCC to acute kindly injury
    (Max Planck-The University of Tokyo Center for Integrative Inflammology Symposium 2017 2017)
  • 3. 血中タンパク質AIMによる異物除去機構を介した疾患の制御
    (第35回内分泌代謝学サマーセミナー 2017)
  • 1. Expression of AIM by large peritoneal macrophages (LPMs) and its role in phagocytic activity
    (Keystone Symposium, Mononuclear Phagocytes in Health, Immune Defense and Disease (D3) 2017)
Education (3):
  • 2001 - 2004 The University of Tokyo Graduate School of Agricultural and Life Sciences Applied Biological Chemistry
  • 1999 - 2001 The University of Tokyo Graduate School of Agricultural and Life Sciences Applied Biological Chemistry
  • 1997 - 1999 The University of Tokyo
Work history (6):
  • 2023/04 - 現在 The Institute for AIM Medicine Vice Director
  • 2016/01 - 2023/03 The University of Tokyo Graduate School of Medicine Center for Disease Biology and Integrative Medicine Associate Professor
  • 2014/07 - 2016/01 The University of Tokyo Graduate School of Medicine Center for Disease Biology and Integrative Medicine Project Associate Professor
  • 2007/07 - 2014/07 The University of Tokyo Graduate School of Medicine Center for Disease Biology and Integrative Medicine Lecturer
  • 2005/10 - 2007/07 The University of Tokyo Graduate School of Medicine Center for Disease Biology and Integrative Medicine Assistant Professor
Show all
Association Membership(s) (2):
Japan Society for Immunology ,  The Molecular Biology Society Japan
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page